Immunome Research : Citations & Metrics Report
Articles published in Immunome Research have been cited by esteemed scholars and scientists all around the world. Immunome Research has got h-index 15, which means every article in Immunome Research has got 15 average citations.
Following are the list of articles that have cited the articles published in Immunome Research.
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Year wise published articles |
40 | 13 | 7 | 20 |
Year wise citations received |
111 | 109 | 84 | 74 |
Journal total citations count | 817 |
Journal impact factor | 9.00 |
Journal 5 years impact factor | 10.13 |
Journal cite score | 13.75 |
Journal h-index | 15 |
Journal h-index since 2019 | 13 |
Important citations (1540)
ahmad ta, eweida ae, el-sayed lh. vaccine reports. |
|
training pg (2007) leonard moise, phd. vaccine 25: 3179-3191. |
|
terry fe, moise l, martin rf, torres m, pilotte n, et al. (2015) time for t? immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases. expert review of vaccines 14: 21-35. |
|
eugenio caoili s (2013) antidotes, antibody-mediated immunity and the future of pharmaceutical product development. human vaccines & immunotherapeutics 9: 294-299. |
|
fulton km, twine sm (2013) immunoproteomics: current technology and applications. immunoproteomics: methods and protocols pp: 21-57. |
|
castelli m, cappelletti f, diotti ra, sautto g, criscuolo e, et al. (2013) peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of t-cell-activating peptides. clinical and developmental immunology. |
|
yin l, chen x, vicini p, rup b, hickling tp (2015) therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein products. cellular immunology 295: 118-126. |
|
lu zj, deng sj, huang dg, he y, lei m, et al. (2012) frontier of therapeutic antibody discovery: the challenges and how to face them. world j biol chem 3: 187-196. |
|
parvege mm, rahman m, nibir ym, hossain ms (2016) two highly similar laeddtnaqkt and ltdkigtei epitopes in g glycoprotein may be useful for effective epitope based vaccine design against pathogenic henipavirus. computational biology and chemistry 61: 270-280. |
|
training pg (2007) leonard moise, phd. vaccine 25: 3179-3191. |
|
de groot a, liu r, moise l, tassone r, ali m, et al. (2015) highly cross-conserved burkholderia t cell epitopes generate effector t cell responses in vitro. |
|
tambunan us, sipahutar fr, parikesit aa, kerami d, et al. (2016) vaccine design for h5n1 based on b-and t-cell epitope predictions. bioinformatics and biology insights 10: 27. |
|
de groot as, ross tm, levitz l, messitt tj, tassone r, et al (2015) c3d adjuvant effects are mediated through the activation of c3d-specific autoreactive t cells. immunology and cell biology 93: 189-197. |
|
terry fe, moise l, martin rf, torres m, pilotte n, et al. (2015) time for t? immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases. expert review of vaccines 14: 21-35. |
|
moise l, gutierrez a, kibria f, martin r, tassone r, et al. (2015) ivax: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. human vaccines & immunotherapeutics 11: 2312-2321. |
|
wei r, yang c, zeng m, terry f, zhu k, et al. (2012) a dominant ev71-specific cd4+ t cell epitope is highly conserved among human enteroviruses. plos one 7: e51957. |
|
moise l, terry f, ardito m, tassone r, latimer h, et al. (2013) universal h1n1 influenza vaccine development: identification of consensus class ii hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011. human vaccines & immunotherapeutics 9: 1598-1607. |
|
de groot as, einck l, moise l, chambers m, ballantyne j, et al. (2013) making vaccines “on demand” a potential solution for emerging pathogens and biodefense?. human vaccines & immunotherapeutics 9: 1877-1884. |
|
rudra ds, pal u, maiti nc, reiter rj, swarnakar s (2013) melatonin inhibits matrix metalloproteinaseâ€9 activity by binding to its active site. journal of pineal research 54: 398-405. |
|
cousens lp, tassone r, mazer bd, ramachandiran v, scott dw, et al. (2013) tregitope update: mechanism of action parallels ivig. autoimmunity reviews 12: 436-443. |
|